Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.47

Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.47, versus $0.56 reported last year. Revenue for the quarter came in at $580 million, versus $557 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Goldman Regional Director in US Adjusts List of Top Names
• Nike (NKE) PT Lowered to $72 at Bernstein SocGen Group
• JPMorgan Reiterates Overweight Rating on Adani Ports & Special Economic Zone (ADSEZ:IN)